The inadequate GPR35 signaling is closely associated with an increased risk of inflammatory bowel diseases (IBDs), both ulcerative colitis and Crohn’s diseases, as well as primary sclerosing cholangitis24–26. This evidence concerns the gene GPR35 and inflammatory bowel disease.